Arrow-right Camera

Color Scheme

Subscribe now

This column reflects the opinion of the writer. Learn about the differences between a news story and an opinion column.

Global Fund is a win-win

Kudos to Willie Dickerson for pointing out our planet’s most effective force to battle pandemic disease: The Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria (“Fighting pandemic disease,” Sept. 1).

Poverty is both a cause and a result of disease. Did you know that just one-fourth of 1% of our federal budget goes to global health? Yet the Global Fund strengthens health care systems to fight sudden outbreaks such as Ebola, increases stability in fragile countries, and engenders economic benefits by protecting the health of families, particularly the bread-winners. But growing drug resistance, underfunding and diminishing political will threaten its progress.

Malaria-free countries have five times the economic growth than countries with malaria. Eleven of the top 15 U.S. export markets were once U.S. foreign aid recipients. The Global Fund to Fight AIDS, TB and Malaria is a win-win. It is imperative that we support it.

Donna Schindler Munro

Bremerton, Wash.

Letters Policy

The Spokesman-Review invites original letters on local topics of public interest. Your letter must adhere to the following rules:

  • No more than 250 words
  • We reserve the right to reject letters that are not factually correct, racist or are written with malice.
  • We cannot accept more than one letter a month from the same writer.
  • With each letter, include your daytime phone number and street address.
  • The Spokesman-Review retains the nonexclusive right to archive and re-publish any material submitted for publication.

Unfortunately, we don’t have space to publish all letters received, nor are we able to acknowledge their receipt. (Learn more.)

Submit letters using any of the following:

Our online form
Submit your letter here
Mail
Letters to the Editor
The Spokesman-Review
999 W. Riverside Ave.
Spokane, WA 99201
Fax
(509) 459-3815

Read more about how we crafted our Letters to the Editor policy